Oral semaglutide vs DPP-4 inhibitors in reducing risk of cognitive impairment in elderly patients with HFpEF and obesity: comment

Enriched record

Pierre Odic, Olivier Nardi, Laura Foucault‐Fruchard

Abstract

No public abstract is available from the verified source records.

Authors

Institutions

Provenance

crossref

Confidence 100%

Referenced works

No local reference links have been materialized yet.

No local citing links have been materialized yet.

10.1007/s11739-026-04499-4

10.1007/s11739-026-04499-4 · 2026

10.1111/jep.13341

10.1111/jep.13341 · 2020

10.1056/nejm199712253372606

10.1056/nejm199712253372606 · 1997

10.1097/ede.0b013e3181a819a1

10.1097/ede.0b013e3181a819a1 · 2009

Unresolved referenced work

Kept as external metadata until matched

10.1097/ede.0b013e3181a819a1

10.1097/ede.0b013e3181a819a1 · doi-reference

10.1056/nejm199712253372606

10.1056/nejm199712253372606 · doi-reference

10.1111/jep.13341

10.1111/jep.13341 · doi-reference

10.1007/s11739-026-04499-4

10.1007/s11739-026-04499-4 · doi-reference